CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease

@inproceedings{As2016CB2CR,
  title={CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease},
  author={Ester As{\'o} and Isidro Ferrer},
  booktitle={Front. Neurosci.},
  year={2016}
}
The CB2 receptor is one of the components of the endogenous cannabinoid system, a complex network of signaling molecules and receptors involved in the homeostatic control of several physiological functions. Accumulated evidence suggests a role for CB2 receptors in Alzheimer's disease (AD) and indicates their potential as a therapeutic target against this neurodegenerative disease. Levels of CB2 receptors are significantly increased in post-mortem AD brains, mainly in microglia surrounding… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 14 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Sisyphus in Neverland

Journal of Alzheimer's disease : JAD • 2017

References

Publications referenced by this paper.
Showing 1-10 of 99 references

WIN 552122 attenuates amyloidbetainduced neuroinflammation in rats through activation of cannabinoid receptors and PPARγ pathway

G. Fakhfouri, A. Ahmadiani, +3 authors A. andHaeri
Neuropharmacology • 2012
View 4 Excerpts
Highly Influenced

Alzheimer’s disease

S Salloway
Lancet. doi: 10.1016/S0140- • 2016

Similar Papers

Loading similar papers…